Chemigenetic Calcium Indicators Brightness Photostability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing genetically encoded fluorescent calcium indicators (GECIs) have limitations in brightness, photostability, and spectral range, which hinder their effectiveness in imaging neuronal activity.

Innovation Solution

Development of chemigenetic calcium indicators that combine a calcium-binding protein domain with a ligand binding protein domain, such as HaloTag, and a dye-ligand conjugate, enhancing brightness, photostability, and spectral range.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If genetically encoded fluorescent calcium indicators (GECIs) are used, then calcium imaging capability is provided, but brightness and photostability are limited

Engineering Contradiction:
ImprovebrightnessVSAvoidphotostability
Core Design Contradiction:
Illumination intensityVSReliability

Solution Approach 1:

The patent combines a calcium-binding protein domain (genetic component) with a small-molecule fluorescent dye (synthetic component) to create a hybrid chemigenetic calcium indicator. This composite structure integrates the calcium selectivity and biological compatibility of GECIs with the superior brightness and photostability of synthetic dyes, directly resolving the contradiction between imaging capability and optical performance.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If fluorescent protein domains are used in GECIs, then calcium-binding functionality is achieved, but spectral range is limited

Engineering Contradiction:
Improvespectral rangeVSAvoidcalcium-binding functionality
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent divides the calcium indicator into two functional segments: a calcium-binding protein domain that maintains calcium selectivity and a small-molecule fluorescent dye that provides enhanced spectral properties. This segmentation allows each component to optimize its specialized function while working together as an integrated system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the optical parameters of the indicator by replacing the fluorescent protein chromophore with a small-molecule fluorescent dye, thereby expanding the spectral range while preserving the calcium-binding functionality through the protein domain.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If small molecule synthetic fluorophores are used, then brightness and photostability are improved, but calcium-selective binding is lost

Engineering Contradiction:
ImprovephotostabilityVSAvoidcalcium-selective binding
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent merges the calcium-binding capability of protein domains with the superior optical properties of small-molecule fluorescent dyes through a covalent linkage, creating a unified chemigenetic indicator that exhibits both calcium selectivity and enhanced photostability simultaneously.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The chemigenetic calcium indicators provide improved brightness, photostability, and spectral range compared to traditional fluorescent proteins, enabling more effective imaging of neuronal activity.

Implementation Method 1

determining changes in fluorescence, the chemigenetic calcium indicator comprising a ligand binding protein domain having a calcium-binding protein domain and a dye-ligand conjugate attached thereto

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12275767B2Chemigenetic calcium indicators
Publication Date: 2025.04.15 HOWARD HUGHES MEDICAL INST
  • US12275767B2 patent drawing
  • US12275767B2 patent drawing
  • US12275767B2 patent drawing

AI summary

A chemigenetic calcium indicator and a method of measuring calcium are provided. The chemigenetic calcium indicator includes a calcium-binding protein domain attached to a ligand binding protein domain. The method of measuring calcium includes administering a chemigenetic calcium indicator to a subject and determining changes in fluorescence, the chemigenetic calcium indicator including a ligand binding protein domain having a calcium-binding protein domain and a dye-ligand conjugate attached thereto.